FOR DENTAL PROVIDERS
CHAIRSIDE ADD-ON
Oral Microbiome & Systemic Risk Panel
One non-invasive oral swab. A single multiplex PCR panel screening for periodontal and cardiovascular-linked oral pathogens — run in our CLIA-certified, high-complexity laboratory.
Why Add This
Built to fit into a chairside visit, not around it
One chairside sample
No added chairtime, equipment, or clinical training needed.
Positions your practice
At the forefront of molecular, prevention-focused dental care.
Opens a broader conversation
With a clear referral pathway when findings warrant follow-up.
Simple for your office
Logistics are handled by MnM — nothing new for your team to manage.
What It Screens For
Four panel categories, one swab
| Category | Organisms | Why It Matters |
|---|---|---|
| HPV-16 & Oropharyngeal Risk | HPV-16 DNA | Present in an estimated 70–90% of HPV-associated oropharyngeal (throat) cancer cases; may help flag risk years before any visible lesion appears. |
| Cardiovascular-Linked Pathogens | P. gingivalis, S. sanguis, E. faecalis, C. pneumoniae | Organisms reported in atherosclerotic plaque and infective endocarditis cases. |
| Core Oral Pathogens | S. mutans, C. albicans, and other caries-, periodontal-, and endodontic-associated organisms | Supports routine risk stratification and treatment planning. |
| Hepatitis C Screening | Hepatitis C | Supports bloodborne-exposure risk awareness relevant to dental care. |
How It Works
From swab to chairside report
01
Collect
A chairside oral swab — no invasive procedure.
02
Ship
Sample ships to our CLIA-certified, high-complexity lab.
03
Analyze
Multiplex PCR identifies and quantifies target organisms in one run.
04
Report
A patient-friendly report returns to your practice for the chart.
Ordering & Billing — this panel is offered as a patient-paid service; no insurance claim is filed by your office. MnM supplies the sample kit, prepaid shipping, and instructions.
Ask About Pricing →
Laboratory-Developed Test Disclosure: This test was developed, and its performance characteristics determined, by MNM Laboratory. It has not been cleared or approved by the U.S. Food and Drug Administration. It is performed in a CLIA-certified, high-complexity laboratory and is intended for informational and risk-assessment purposes to support — not replace — clinical judgment, diagnosis, and referral. It is not intended to diagnose, treat, cure, or prevent any disease.